Medicrea Gains FDA Clearance for 3D-Printed Ti Interbody
Medicrea received FDA 510(k) clearance to market IB3D™ 3D-printed interbody devices, and introduced its AdapTEK™ in-house additive manufacturing technology....
Nov 27, 2017,
Medicrea Gains FDA Clearance for 3D-Printed Ti Interbody
Life Spine Launches SIMPACT TRI-FIN Sacroiliac Joint Fixation Screws
Life Spine commenced limited launch of the SIMPACT™ TRI-FIN sacroiliac joint fixation screw....
Nov 21, 2017,
Highmark Issues Exclusive Coverage Policy for coflex Interlaminar Stabilization
Highmark is reported to be the first and only private payor to issue exclusive positive coverage for Paradigm Spine’s coflex®...
Nov 20, 2017,
OTA Recap: Trauma Surgeon Identifies Areas for Device Improvement
Two of the greater challenges that trauma surgeons face today are an increased number of complex fractures and complications from...
Nov 17, 2017,
Titan Spine’s First Endoskeleton Interbody Fusion Cases in Australia
Titan Spine entered the Australian market with its Endoskeleton® interbody fusion devices and surface technology....
Nov 16, 2017,
DJO Global 3Q17 Revenue
DJO Global posted 3Q17 revenue of US $290.9MM, +1.3% vs. 3Q16, and YTD revenue of $873.9MM, +1.7% vs. the prior...
Nov 16, 2017,
PeerWell Launches App for Outpatient Joint Recon Recovery
PeerWell is launching the PreHab to ReHab program for patients undergoing hip or knee replacement in outpatient centers....
Nov 16, 2017,
Additive, Materials and Robotics Remain Spine Companies’ Product Focus
Topics that resonated in exhibit hall conversations and surgeon presentations at NASS 2017 were advancements in additive manufacturing, replacement or...
Nov 16, 2017,
Alphatec Spine Posts 3Q17 Revenue
Alphatec Spine posted 3Q17 revenue of US $23.1MM, -13.5% vs. 3Q16, and YTD revenue of $75.5MM, -4.6% vs. the prior year....
Nov 15, 2017,
Globus Medical Announces 3Q17 Revenue
Globus Medical reported 3Q17 revenue of US $151.7MM, +11.9% vs. 3Q16, and YTD revenue of $459.9MM, +11.5% vs. the prior...
Nov 15, 2017,
Loading new posts...
No more posts
